Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens
CONCLUSION: Smoking status does not appear to independently influence the clinical outcomes to first-line ICI-based regimens in patients with mRCC. Nonetheless, patient counseling on tobacco cessation remains a crucial aspect of managing patients with mRCC, as it significantly reduces all-cause mortality.PMID:38630540 | DOI:10.1093/oncolo/oyae072
Source: The Oncologist - Category: Cancer & Oncology Authors: Eddy Saad Georges Gebrael Karl Semaan Marc Eid Ren ée Maria Saliby Chris Labaki Nicolas Sayegh J Connor Wells Kosuke Takemura Matthew Scott Ernst Audreylie Lemelin Naveen S Basappa Lori A Wood Thomas Powles D Scott Ernst Aly-Khan A Lalani Neeraj Agarwal Source Type: research
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Kidney Cancer | Renal Cell Carcinoma | Smokers